Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1982 Aug;14(2):159–170. doi: 10.1111/j.1365-2125.1982.tb01957.x

Assessment of drug therapy in inflammatory bowel disease.

H J Hodgson
PMCID: PMC1427754  PMID: 7049211

Full text

PDF
160

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andre C., Descos L., Landais P., Fermanian J. Laboratory supplementation of Crohn's disease activity index. Lancet. 1980 Sep 13;2(8194):594–595. doi: 10.1016/s0140-6736(80)92032-2. [DOI] [PubMed] [Google Scholar]
  2. BARON J. H., CONNELL A. M., LENNARD-JONES J. E. VARIATION BETWEEN OBSERVERS IN DESCRIBING MUCOSAL APPEARANCES IN PROCTOCOLITIS. Br Med J. 1964 Jan 11;1(5375):89–92. doi: 10.1136/bmj.1.5375.89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BROBERGER O., PERLMANN P. Autoantibodies in human ulcerative colitis. J Exp Med. 1959 Nov 1;110:657–674. doi: 10.1084/jem.110.5.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bendixen G., Goltermann N., Jarnum S., Jensen K. B., Weeke B., Westergaard H. Immunoglobulin and albumin turnover in ulcerative colitis. Scand J Gastroenterol. 1970;5(5):433–441. [PubMed] [Google Scholar]
  5. Bendixen G., Jarnum S., Soltoft J., Westergaard H., Weeke B., Yssing M. IgG and albumin turnover in Crohn's disease. Scand J Gastroenterol. 1968;3(5):481–489. doi: 10.3109/00365526809179907. [DOI] [PubMed] [Google Scholar]
  6. Best W. R., Becktel J. M., Singleton J. W., Kern F., Jr Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976 Mar;70(3):439–444. [PubMed] [Google Scholar]
  7. Best W. R., Becktel J. M., Singleton J. W. Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI). Gastroenterology. 1979 Oct;77(4 Pt 2):843–846. [PubMed] [Google Scholar]
  8. Brahme F., Fork F. T. Dynamic aspects of colonic Crohn's disease. Radiologe. 1975 Dec;15(12):463–468. [PubMed] [Google Scholar]
  9. Buckell N. A., Gould S. R., Day D. W., Lennard-Jones J. E., Edwards A. M. Controlled trial of disodium cromoglycate in chronic persistent ulcerative colitis. Gut. 1978 Dec;19(12):1140–1143. doi: 10.1136/gut.19.12.1140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Burnham W. R., Lennard-Jones J. E., Hecketsweiler P., Colin R., Geffroy Y. Oral BCG vaccine in Crohn's disease. Gut. 1979 Mar;20(3):229–233. doi: 10.1136/gut.20.3.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. COOKE W. T., FOWLER D. I., COX E. V., GADDIE R., MEYNELL M. J. The clinical significance of seromucoids in regional ileitis and ulcerative colitis. Gastroenterology. 1958 May;34(5):910–919. [PubMed] [Google Scholar]
  12. Campieri M., Lanfranchi G. A., Bazzocchi G., Brignola C., Sarti F., Franzin G., Battocchia A., Labo G., Dal Monte P. R. Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas. Lancet. 1981 Aug 8;2(8241):270–271. doi: 10.1016/s0140-6736(81)90523-7. [DOI] [PubMed] [Google Scholar]
  13. De Dombal F. T., Burton I. L., Clamp S. E., Goligher J. C. Short-term course and prognosis of Crohn's disease. Gut. 1974 Jun;15(6):435–443. doi: 10.1136/gut.15.6.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Dearing W. H., McGuckin W. F., Elveback L. R. Serum alpha 1-acid glycoprotein in chronic ulcerative colitis. Gastroenterology. 1969 Feb;56(2):295–303. [PubMed] [Google Scholar]
  15. Dronfield M. W., Langman M. J. Comparative trial of sulphasalazine and oral sodium cromoglycate in the maintenance of remission in ulcerative colitis. Gut. 1978 Dec;19(12):1136–1139. doi: 10.1136/gut.19.12.1136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ferguson R., Allan R. N., Cooke W. T. A study of the cellular infiltrate of the proximal jejunal mucosa in ulcerative colitis and Crohn's disease. Gut. 1975 Mar;16(3):205–208. doi: 10.1136/gut.16.3.205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Gardner R. C., Feinerman A. E., Kantrowitz P. A., Gottblatt S., Loewenstein M. S., Zamcheck N. Serial carcinoembryonic antigen (CEA) blood levels in patients with ulcerative colitis. Am J Dig Dis. 1978 Feb;23(2):129–133. doi: 10.1007/BF01073187. [DOI] [PubMed] [Google Scholar]
  18. Geffen N., Darnborough A., De Dombal F. T., Watkinson G., Goligher J. C. Radiological signs of ulcerative colitis: assessment of their reliability by means of observer variation studies. Gut. 1968 Apr;9(2):150–156. doi: 10.1136/gut.9.2.150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Goldberg H. I., Caruthers S. B., Jr, Nelson J. A., Singleton J. W. Radiographic findings of the National Cooperative Crohn's Disease Study. Gastroenterology. 1979 Oct;77(4 Pt 2):925–937. [PubMed] [Google Scholar]
  20. Goodman M. J., Skinner J. M., Truelove S. C. Abnormalities in the apparently normal bowel mucosa in Crohn's disease. Lancet. 1976 Feb 7;1(7954):275–278. doi: 10.1016/s0140-6736(76)91404-5. [DOI] [PubMed] [Google Scholar]
  21. Gould S. R., Brash A. R., Conolly M. E., Lennard-Jones J. E. Studies of prostaglandins and sulphasalazine in ulcerative colitis. Prostaglandins Med. 1981 Feb;6(2):165–182. doi: 10.1016/0161-4630(81)90088-4. [DOI] [PubMed] [Google Scholar]
  22. Harvey R. F., Bradshaw J. M. A simple index of Crohn's-disease activity. Lancet. 1980 Mar 8;1(8167):514–514. doi: 10.1016/s0140-6736(80)92767-1. [DOI] [PubMed] [Google Scholar]
  23. Harvey R. F., Bradshaw M. J. Measuring Crohn's disease activity. Lancet. 1980 May 24;1(8178):1134–1135. doi: 10.1016/s0140-6736(80)91577-9. [DOI] [PubMed] [Google Scholar]
  24. Heatley R. V., Calcraft B. J., Rhodes J., Owen E., Evans B. K. Disodium cromoglycate in the treatment of chronic proctitis. Gut. 1975 Jul;16(7):559–563. doi: 10.1136/gut.16.7.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Hill R. B., Kent T. H., Hansen R. N. Clinical usefulness of rectal biopsy in Crohn's disease. Gastroenterology. 1979 Oct;77(4 Pt 2):938–944. [PubMed] [Google Scholar]
  26. Hodgson H. J., Potter B. J., Jewell D. P. Humoral immune system in inflammatory bowel disease: I. Complement levels. Gut. 1977 Sep;18(9):749–753. doi: 10.1136/gut.18.9.749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Jensen K. B., Jarnum S., Koudahl G., Kristensen M. Serum orosomucoid in ulcerative colitis: its relation to clinical activity, protein loss, and turnover of albumin and IgG. Scand J Gastroenterol. 1976;11(2):177–183. [PubMed] [Google Scholar]
  28. Jones J. H., Lennard-Jones J. E., Morson B. C., Chapman M., Sackin M. J., Sneath P. H., Spicer C. C., Card W. I. Numerical taxonomy and discriminant analysis applied to non-specific colitis. Q J Med. 1973 Oct;42(168):715–732. [PubMed] [Google Scholar]
  29. LOCKHART-MUMMERY H. E., MORSON B. C. CROHN'S DISEASE OF THE LARGE INTESTINE. Gut. 1964 Dec;5:493–509. doi: 10.1136/gut.5.6.493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Lloyd-Still J. D., Green O. C. A clinical scoring system for chronic inflammatory bowel disease in children. Dig Dis Sci. 1979 Aug;24(8):620–624. doi: 10.1007/BF01333706. [DOI] [PubMed] [Google Scholar]
  31. MATTHEWS C. M. The theory of tracer experiments with 131I-labelled plasma proteins. Phys Med Biol. 1957 Jul;2(1):36–53. doi: 10.1088/0031-9155/2/1/305. [DOI] [PubMed] [Google Scholar]
  32. Mayberry J., Rhodes J., Hughes L. E. Incidence of Crohn's disease in Cardiff between 1934-1977. Gut. 1979 Jul;20(7):602–608. doi: 10.1136/gut.20.7.602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Miller D. S., Keighley A. C., Langman M. J. Changing patterns in epidemiology of Crohn's disease. Lancet. 1974 Sep 21;2(7882):691–693. doi: 10.1016/s0140-6736(74)93265-6. [DOI] [PubMed] [Google Scholar]
  34. Monteiro E., Fossey J., Shiner M., Drasar B. S., Allison A. C. Antibacterial antibodies in rectal and colonic mucosa in ulcerative colitis. Lancet. 1971 Feb 6;1(7693):249–250. doi: 10.1016/s0140-6736(71)90997-4. [DOI] [PubMed] [Google Scholar]
  35. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. doi: 10.1038/bjc.1977.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Phillpotts R. J., Hermon-Taylor J., Teich N. M., Brooke B. N. A search for persistent virus infection in Crohn's disease. Gut. 1980 Mar;21(3):202–207. doi: 10.1136/gut.21.3.202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Present D. H., Korelitz B. I., Wisch N., Glass J. L., Sachar D. B., Pasternack B. S. Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. N Engl J Med. 1980 May 1;302(18):981–987. doi: 10.1056/NEJM198005013021801. [DOI] [PubMed] [Google Scholar]
  38. Prior P., Gyde S., Cooke W. T., Waterhouse J. A., Allan R. N. Mortality in Crohn's disease. Gastroenterology. 1981 Feb;80(2):307–312. [PubMed] [Google Scholar]
  39. Shorter R. G., Cardoza M., Spencer R. J., Huizenga K. A. Further studies on in vitro cytotoxicity of lymphocytes from patients with ulcerative and granulomatous colitis for allogeneic colonic epithelial cells, including the effects of colectomy. Gastroenterology. 1969 Feb;56(2):304–309. [PubMed] [Google Scholar]
  40. Singer H. C., Anderson J. G., Frischer H., Kirsner J. B. Familial aspects of inflammatory bowel disease. Gastroenterology. 1971 Oct;61(4):423–430. [PubMed] [Google Scholar]
  41. Singleton J. W., Law D. H., Kelley M. L., Jr, Mekhjian H. S., Sturdevant R. A. National Cooperative Crohn's Disease Study: adverse reactions to study drugs. Gastroenterology. 1979 Oct;77(4 Pt 2):870–882. [PubMed] [Google Scholar]
  42. TRUELOVE S. C., WITTS L. J. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955 Oct 29;2(4947):1041–1048. doi: 10.1136/bmj.2.4947.1041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Thaw P. A., Albutt E. C. A critical evaluation of a serum sermucoid assay and its replacement by a serum alpha 1 acid glycoprotein assay. Ann Clin Biochem. 1980 May;17(3):140–143. doi: 10.1177/000456328001700307. [DOI] [PubMed] [Google Scholar]
  44. Truelove S. C., Jewell D. P. Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet. 1974 Jun 1;1(7866):1067–1070. doi: 10.1016/s0140-6736(74)90552-2. [DOI] [PubMed] [Google Scholar]
  45. Van Hees P. A., Van Lier H. J., Van Elteren P. H., Driessen M., Van Hogezand R. A., Ten Velde G. P., Bakker J. H., Van Tongeren J. H. Effect of sulphasalazine in patients with active Crohn's disease: a controlled double-blind study. Gut. 1981 May;22(5):404–409. doi: 10.1136/gut.22.5.404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Weeke B., Jarnum S. Serum concentration of 19 serum proteins in Crohn's disease and ulcerative colitis. Gut. 1971 Apr;12(4):297–302. doi: 10.1136/gut.12.4.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Winship D. H., Summers R. W., Singleton J. W., Best W. R., Becktel J. M., Lenk L. F., Kern F., Jr National Cooperative Crohn's Disease Study: study design and conduct of the study. Gastroenterology. 1979 Oct;77(4 Pt 2):829–842. [PubMed] [Google Scholar]
  48. van Hees P. A., van Elteren P. H., van Lier H. J., van Tongeren J. H. An index of inflammatory activity in patients with Crohn's disease. Gut. 1980 Apr;21(4):279–286. doi: 10.1136/gut.21.4.279. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES